Genetic studies have implicated a polymorphic repeat sequence in exon 3 of the human dopamine D4 receptor in various behavioral and psychiatric disorders. Functionally various repeat variants are nearly identical, but whether these have different effects on gene expression has not been studied. To study the role of the repeat sequences on expression independently from its structural and functional effects at the protein level, we introduced these sequences immediately upstream of the promoter and in the 3 0 untranslated region of a luciferase reporter vector. In this report, we demonstrate that the repeat sequence can both modulate promoter activity and alter expression post-transcriptionally. The repeat sequence can serve as a substrate for a nuclear binding factor and all the three repeat variants can suppress promoter activity. Placement of the three repeat variants downstream from the luciferase gene in the expression vector shows, however, that the D4.7 repeat sequence has significantly suppressed expression of the reporter compared to the D4.2 and D4.4 repeats, likely via mechanisms involving RNA stability or translational efficiency. These data indicate that the various D4 repeat sequences have different effects on expression, which may explain its potential role in behavioral disorders.
INTRODUCTION
The dopamine D4 receptor is a D2-like receptor that mediates its signal via activation of heterotrimeric Gai/o proteins. The D4 dopamine receptor is widely expressed in the central nervous system, particularly the retina, frontal cortex, hippocampus, amygdala and hypothalamus. The receptor is the target for various antipsychotics, including atypical neuroleptics like clozapine. 1 While the receptor has been implicated in various psychiatric, behavioral and neurological disorders, particularly in genetic studies, there is no universal agreement between the many studies done on the relationship between this receptor and various disorders. [1] [2] [3] The human dopamine D4 receptor located on chromosome 11p15.5 has a highly variable number of tandem repeats in the coding sequence. [4] [5] [6] [7] [8] Various genetic studies using this polymorphism have implicated a seven-repeat allele in behavioral disorders, as for example, in novelty-seeking behavior and attention deficit hyperactivity disorder (ADHD). [9] [10] [11] The three most common polymorphic variants of the receptor, D4.2, D4.4 and D4.7, are functionally and pharmacologically nearly indistinguishable from each other. 6, 8, 12, 13 However, mice deficient in D4 expression display increased anxiety 14 and altered exploratory behavior. 15 Dopamine D4 receptor activation can modulate many intracellular signaling cascades in heterologous expression systems, 1 and has been shown to inhibit adenylyl cyclase, 16, 17 inhibit GABAa currents, 18 and stimulate extracellular regulated kinase (ERK) and depress NMDA channel activity via transactivation of the plateletderived growth factor receptor-b in the central nervous system. 19 The biological role of this receptor is less well established, but studies with D4-deficient mice and selective D4 receptor antagonists support a role of this receptor in attention and cognition. 14, 15, 20, 21 To date, 36 variants of the polymorphic 48 bp repeat sequence have been identified in humans, and these repeat sequences can be combined into many allelic variants. Up to 11 copies of the repeat, in tandem, have been reported. [4] [5] [6] [7] [8] The most frequently occurring variant in the human population is the so-called four-repeat version (D4.4, B70%), followed by the D4.7 (B20%) and D4.2 (B5%). However, there can be considerable differences in the frequency distribution of the different alleles in populations of different ethnic origins. 4, 5, 7 It is argued that the D4.7 allele is seen more frequently than expected, suggesting a positive selection for this variant. 4 This particular variant is also associated in various studies with ADHD. [9] [10] [11] To date, only a limited number of studies have addressed whether the different variants can differentially modulate receptor function. The different receptor variants show no major differences in pharmacology. 6, 8, 13 While the different variants show no difference in their ability to couple to Gai/o 12 proteins, there is a small two-to three-fold difference in potency between the D4.7 and the D4.4, D4.2 and D4.9 variants in coupling to adenylyl cyclase. 13, 22 The objective of this study was to explore whether the repeat sequences can modulate expression by integrating it at various positions in a luciferase reporter vector. The results of the experiments suggest that the D4 repeat sequences can modulate expression and that the repeat variants may affect RNA stability and/or translational efficiency differently.
RESULTS AND DISCUSSION
In silico analysis of the polymorphic repeat sequence in the human D4 receptor identified the presence of multiple putative binding sites for transcription factors, using the object-oriented Transcription Factors Database. 23 Considering the repeated nature of the sequences, we considered the possibility that the various repeat variants might affect the expression of the D4 gene. To analyze if the sequence was indeed a substrate for DNA-binding proteins, we synthesized a double-stranded (ds) 72 base pair (bp) oligonucleotide that contained the core 48 bp of the repeat with 12 bp flanking repeat sequence. In electrophoretic mobility shift assays (EMSA) using a nuclear extract from HeLa cells, we observed that co-incubation of radiolabeled 72 bp repeat oligonucleotide with the extract retarded the migration of the oligonucleotide, indicative of the association with a factor present in the nuclear extract (Figure 1a) . The amount of oligonucleotide that shifted in migration to a higher Figure 1 Autoradiograms of EMSA with a 72 bp radiolabeled oligonucleotide containing D4 repeat sequences and HeLa cell nuclear extract. (a) The radiolabeled oligonucleotide was incubated with different amounts of nuclear extract. The amounts of nuclear extract are indicated. The bottom band is free oligonucleotide, while the top band represents oligonucleotide retarded in migration due to its interaction with a factor in the nuclear extract. Increasing amounts of extract decrease the amount of free oligonucleotide and increases the amount of oligonucleotide bound to nuclear factors. (b) The radiolabeled oligonucleotide was incubated with 5 lg nuclear extract in the absence of competitor DNA (no competing oligonucleotide) or with 10-, 50-and 100-fold excess of the competing unlabeled 72 bp repeat oligonucleotide (10 Â , 50Â , 100 Â repeat) or a 100-fold excess (100 Â ) of oligonucleotide mixtures that can disrupt the binding of AP-1, -2, -3 (AP1/2/3); SP1, NF1 (SP1/NF1); CREB, Oct1 (CREB/Oct1) and GRE, NFjB (GRE/NFjB). The top of the gel is indicated. The bands indicated by the arrows labeled 1 display retarded migration of the radiolabeled 72 bp oligonucleotide due to its interaction with a nuclear factor, while the bottom bands indicated by the arrow labeled 2 is free oligonucleotide. The gel shift of the 72 bp radiolabeled oligonucleotide is prevented by co-incubation with an excess of unlabeled 72 bp oligonucleotide, but not by oligonucleotides that serve as binding sites for various known transcription factors.
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O Schoots and HHM Van Tol molecular weight increased when it was incubated with larger amounts of HeLa nuclear extract, while as a consequence the amount of free radiolabeled oligonucleotide diminished. At higher concentrations of the Hela nuclear extract, multiple higher molecular weight bands were observed in the gel (Figure 1a) , suggesting the interaction of multiple factors. The factors could be competed off effectively with double-stranded 72 bp unlabeled oligonucleotide, but not by an excess of various oligonucleotides that serve as binding sites for the common transcription factors AP1, -2, -3, SP1, Oct1, NF1, GRE, CREB and NF-kB (Figure 1b) , suggesting that the interaction with the nuclear factors is sequence specific. Additional studies are required to determine which nuclear factors can bind to the multitude of potential recognition sites in the C-rich sequence of the repeat. While HeLa nuclear extract is unlikely to reflect the complement of binding factors present in the brain, these data indicate that the repeat region contains binding sites for nuclear factors that can potentially alter the expression.
In order to investigate whether the repeat sequence could indeed alter the expression and that the change in expression differed between repeat variants, we subcloned different versions of the repeat region in different positions and orientations into a luciferase reporter vector (Figure 2) . In order to determine the effects of the construct on the promoter, independent from putative regulatory roles when present in the coding sequence, we cloned this fragment containing the three common variants (D4.2, D4.4 and D4.7) immediately upstream from the metallothionein (MT-I) promoter in sense (pMTBS-2, -4, -7) and antisense orientation (pMTBA-2, -4, -7). To mimic the presence of this variable sequence further downstream in the transcript, as it is found in the D4 receptor gene, it was cloned 139 bp downstream from the stop codon of the luciferase reporter (pMTSS-2, -4 and -7 (sense orientation); pMTSA-2, -4, -7 (antisense orientation)). These expression constructs were analyzed in the somatomammotrophic cell line GH4C1. The choice of this cell line was several-fold. Dopamine D2 and D4 receptors have been found in the pituitary, 24 and this cell line has been commonly used as a model system to study the role of dopamine D2-like receptors in endocrine regulation. Furthermore, as we noted in a previous study, D4 expression in these cells was also modulated by post-transcriptional mechanisms, which include RNA stability and translational efficiency. 25 This last feature may affect the expression for luciferase mRNAs with the repeat sequences in the 3 0 untranslated region generated with the pMTS constructs.
The expression of luciferase was corrected for transfection efficiency by cotransfection of the b-galactosidase reporter vector pCMVb that drives the LacZ gene from the constitutive cytomegalovirus promoter. The unmodified pMT-I luciferase reporter vector was used as reference for the different experiments, and therefore the data are expressed as a fraction of the expression of this vector. As shown in Table 1 , all constructs, with the exception of the pMTSS-2 construct, show decreased expression. Analysis of all the different constructs reveal that there are significant differences (ANOVA; df 11.63, F 3.7; Po0.0005). The expression constructs with the different repeat variants immediately upstream of the promoter did not differ from each other (ANOVA; df 5.31; F 1.54), while the constructs with the repeat variants downstream from the stop codon show significant differences (ANOVA; df 5.32; F 3.74; Po0.01).
Only the group of expression constructs with the repeat variants in the sense direction downstream from the luciferase gene showed significant differences (ANOVA, df 2.16; F 5.12; P¼0.02). It appears that there is an inverse relationship between repeat length and the expression levels between these constructs, as determined by post hoc analysis on the entire data set, with the Duncan test that adjusts for multiple testing (pMTSS-7 vs -2, Po0.0001; pMTSS-4 vs -2, Po0.005; pMTT-7 vs -4 did not reach significance in this test). Direct comparison of the seven-repeat sequence in the sense vs antisense direction shows a significant three-fold difference (Duncan test, Po0.05), indicating that decreased expression with the seven-repeat sequence is orientation specific. The data indicate that the positioning of a D4 receptor fragment containing the polymorphic repeat sequence decreases expression of the MT-I promoter in an orientation-independent manner, without significant differences between polymorphic variants. Therefore, the three- 
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fold decrease in expression between the seven-repeat in the sense vs antisense direction represents a decrease in expression likely due to the presence of the seven-repeat sequence in the transcript. The post hoc analysis also suggests that expression of the two-repeat sequence in the sense orientation is increased compared to this sequence in the antisense orientation. This suggests that the presence of this shorter sequence variant enhances expression when present in the transcript. Alternatively, it may merely reflect that the suppressing effects on expression are proportional to the length of the repeat sequence.
Insertion of the repeat sequences immediately upstream from the promoter resulted in a two-fold reduction of expression compared to the unmodified expression vector. This repression was orientation-independent and comparable for the two-, four-and seven-repeat alleles. Analysis of the constructs in which the repeat alleles were inserted downstream of the luciferase gene showed that the presence of the seven-repeat sequence in the sense orientation suppressed the expression. These findings indicate that the repeat sequence can serve as a modulator of promoter activity. However, in this heterologous test system, the repeat sequences are not a factor that can mediate differential responses for the repeat variants. Support for the idea that the repeat sequences can serve as a potential site for modulation of promoter activity is that this sequence specifically binds an as-of-yet unknown nuclear factor, and that the repression by the sequence inserted immediately upstream of the promoter is orientation-independent.
The enhanced suppression of luciferase expression by the seven-repeat sequence in the sense direction, downstream of the luciferase cassette, strongly suggests that this sequence has decreased RNA stability or translational efficiency. While the sequence also affects promoter activity, the seven-repeat sequence at the same position in the antisense direction has a three-fold higher expression. Furthermore, there was no difference in expression between the variants with the repeat in the antisense direction in this location. To date, no differences in expression for the different D4 repeat alleles have been reported. However, most of the published comparative studies were focused on differences in pharmacological or functional profile for different D4 variants. These analyses were done in cell lines in which the receptor is stably expressed and selected for high expression, and not designed for exploring differences in expression levels. To our knowledge, no D4 expression studies for the specific alleles have been done in human tissues. It should also be considered that additional factors, such as folding efficiency and receptor turnover, might either blunt or enhance the observed effects of the D4 repeat sequences on expression.
The mechanism by which the repeat sequence reduces expression is unclear. While it could be argued that the inserted sequence may depress transcriptional progress or enhance premature termination, the sequence in the antisense direction does not appear to do so. The repeat sequence is highly C-rich and many KH-domain RNAbinding proteins can bind to such sequences and are known to be involved in various post-transcriptional controls. 26 Indeed, a scan of the D4 sequence for sequences that may modify RNA stability and translational efficiency 27 identified hnRNP K and E binding sites, known as DICE, that are present as a tandem repeated sequence in the 15-lipoxygenase 3 0 untranslated region and suppress translation. 28, 29 This identified consensus sequence is present in the region analyzed and includes sequences in the first repeat unit (a sequence). The observation that the single-stranded sense strand of the repeat 72 bp sequence, but not the antisense strand, could block the mobility shift of the nuclear factor (not shown) is consistent with this finding because KH domain proteins, like hnRNP K, can bind to single-stranded DNA with a similar specificity as to their RNA targets. In the other following repeat units of D4.2, D4.4 and D4.7 are sequences that resemble these putative DICE sequences, but they do not have an equally stringent match. It is possible that the RNA with the seven-repeat sequence adopts a configuration that makes it more likely to be targeted by hnRNPs or that the repeat region provides a related novel target for such regulatory molecules. Whether the native D4.7 in human brain is susceptible to such regulation and displays decreased translational efficiency requires further research, but these studies suggest a potential for differential RNA stability or translational efficiency for different repeat variants. A reduced D4.7 expression may compound the effect of the observed decreased functional potency of this Expression of luciferase reporter vectors with an insertion of a PstI-DpnI fragment of the D4.2, D4.4 and D4.7 dopamine receptor cDNA in the sense (S2, S4, S7) or antisense (A2, A4, A7) direction immediately upstream of the metallothionein-I promoter (pMTB) or downstream into the 3 0 untranslated region (pMTS) of the firefly luciferase reporter gene. Luciferase expression of the constructs was done by cotransfection with the b-galactosidase reporter vector pCMVb into the somatomammotrophic cell line GH4C1. Luciferase expression was measured in arbitrary light units and expressed as a fraction of expression mediated by the unmodified luciferase reporter vector after correction for variability in transfection efficiency, as measured by b-galactosidase activity. The data are expressed as the mean7standard error for duplicate measurements of four to seven experiments. Statistical analysis indicates group differences (ANOVA; df:11,63; F3.7; Po0.0005). Post hoc analyses show that within groups there are only differences in the pMTSS group and that pMTSS-7 is expressed at significant lower levels than pMTSS-2 and PMTSA-7 (Duncan test, Po0.05).
allelic variant of the receptor, and thus contribute to altered susceptibility for behavioral phenotypes, such as ADHD, which are thought to be associated with this allele.
MATERIALS AND METHODS
Electrophoretic Mobility Shift Assay (EMSA)
In order to determine whether the D4 repeat sequence serves as a potential target nuclear for nuclear binding factors, we performed EMSA using a GelShiftt Assay Kit (Stratagene, La Jolla, CA, USA). We synthesized the following 72 bp oligonucleotide sequence (representing sequences found in many of the D4 repeat variants) to serve as double-stranded target; 5 0 -CGACTGTGCGCCCCCCGCGCCCGGCCTCCCC CAGGACCCCTGCGGCCCCGACTGTGCGCCCCCCGCGCC CGG-3 0 . The 72 bp oligonucleotide was labeled using T4 polynucleotide kinase and [g-32 P]ATP (Z6000 Ci/mmol). About 0.1 ng radiolabeled oligonucleotide was incubated with 5 mg of HeLa nuclear extract 30 in 25 ml incubation buffer (included in the kit) for 30 min on ice, as instructed by the manufacturer. The formed complexes were then separated by acrylamide gel electrophoresis and visualized by autoradiography. As a competitor for the observed interactions, we used oligonucleotides for Sp1, NF1/CTF, AP1, AP2, AP3, NFkB, GRE, CREB and Oct1 binding sites, as supplied with the gel shift kit.
Construction of D4 Repeat-Luciferase Reporter Vectors
In order to study the role of the human D4 repeat sequence, we subcloned repeat sequence fragments of D4.2, D4.4 and D4.7 cDNAs 8 contained on the PstI-DpnI fragment into the luciferase reporter pMTI-Luc. The pMTI-Luc vector is a modified version of the luciferase reporter construct pSV2A, 31 in which the SV40 promoter has been replaced with the MT-I promoter. The fragments were cloned by standard blunt-end cloning protocols in the sense (*¼S) and antisense (*¼A) direction immediately upstream of the mouse MT-I promoter into the BamHI site of this vector (pMTB*-2, -4 and -7), or in the SmaI site 139 bp downstream from the stop codon of the luciferase gene (pMTS*-2, -4 and -7).
Cell Culture and Transfection GH4C1 cells were grown as described by us previously, in Ham's F10 medium supplemented with 8% FBS. 24 Cells were harvested by aspiration of the medium, incubation for 1-2 min in PBS, pH 7.2, supplemented with 1 mM EDTA. Cells were resuspended in PBS (2 Â 10 7 cells/ml) and transfected at 41C with the various expression vectors by electroporation, using a BTX 600 Electro Cell manipulator (San Diego, CA; 10:g pCMVb, 20mg Luciferase reporter construct, 250 ml, 300 V, 70 mF). 24, 32 After transfection, the cells were placed on ice for 5 min, resuspended into 12 ml of their growth medium and 1.5 ml was plated onto 35 mm dishes. After 24 h, the cells were harvested in 250 ml Z-buffer (60 mM NaHPO 4 , 40 mM KCl, 1 mM MgSO 4 , pH 7.0) when analyzed for LacZ expression, and in 250 ml harvest buffer (50 mM Tris-MES (2-[N-morpholino]ethanesulfonic acid), pH 7.8; 1 mM dithiothreitol; 0.1% Triton X-100) for luciferase expression measurements.
Reporter Assays
The luciferase reporter assay was done as described by us previously. 24, 32 To measure the luciferase activity, 200 ml cell lysate was combined with 15 ml luciferase cocktail (750 mM Tris-MES, pH 7.8; 150 mM magnesium acetate; 80 mM ATP) in a plastic cuvette, and placed in a luminometer (BioOrbit 1250, Pharmacia, baie d'Urfe, Canada) where 200 ml of 1 mM D-luciferin in 5 mM potassium phosphate, pH 7.5, was dispensed. The peak luminosity was recorded on a chart recorder attached to the apparatus. Appropriate dilutions of the samples in harvest buffer that allowed unambiguous detection of luciferase activity were measured in duplicate for at least three experiments.
To control for differences in transfection efficiency the cells were cotransfected with the LacZ reporter vector pCMVb (Clontech laboratories, Palo Alto, CA, USA). The cells harvested in Z-buffer were analyzed for b-galactosidase expression using a 4-methyl-umbelliferyl-D-galactoside (MUG) fluoremetric assay, as described by us previously. 24, 32 In the final analysis, we corrected for transfection efficiency by stating the effect of the expression as a ratio of the luciferase vs the b-galactosidase expression data.
